• The net cash position of € +7.1m at the end of June 2012 covers the needs of the company’s ongoing R&D programmes at least through to 2013*, including the significant increase in personnel achieved over the last period.
  • The net half-yearly loss reached € - 1.4m (vs. a loss of € -1.2m for the first half of 2011).
  • Subsequent to the accounts closing date, DEINOVE successfully completed the second key milestone of the DEINOL project (development of a process for the production of cellulosic bioethanol), a major breakthrough that triggered the payment of € 1.15m by OSEO (in reimbursable cash advances and grants).

Today, DEINOVE (Alternext Paris: ALDEI), a green biotechnology company, the world's leading specialist in Deinococcus bacteria for biofuels and green chemistry, published its financial results for the half-year ending June 30, 2012.

* even until 2014, assuming the next instalments of the already obtained OSEO cash advances and grants are collected as planned.


See the report